TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The9 ( (NCTY) ) has provided an announcement.
On October 2, 2025, The9 Limited announced that its Singapore investee company, Nanyang Biologics (NYB), plans to go public on Nasdaq through a $1.5 billion business combination with RF Acquisition Corp II. This strategic move is expected to enhance NYB’s capabilities in AI-driven drug discovery, particularly in oncology, by leveraging partnerships with Nvidia, HP, and Equinix. The transaction, anticipated to close in the first half of 2026, will see NYB’s shareholders, including The9, retain a majority stake, potentially positioning NYB as a leader in AI and biotechnology.
More about The9
The9 Limited is a Nasdaq-listed Internet company, established in 2004, focused on becoming a global diversified high-tech Internet company. It operates in online games, Bitcoin mining, and AI-driven drug discovery investments.
Average Trading Volume: 56,367
Technical Sentiment Signal: Sell
Current Market Cap: $132.4M
See more data about NCTY stock on TipRanks’ Stock Analysis page.